Ligand validation:5L6C

6NV: ~{N}-[(2~{R})-1-[[(2~{S})-3-(4-methoxyphenyl)-1-[[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-propan-2-yl]-1-methyl-5~{H}-indene-2-carboxamide

6NV is a Ligand Of Interest in 5L6C designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5L6C_6NV_K_301	17%	22%	0.26	0.843	1.79	1.48	9	8	2	0	100%	0.7
5L6C_6NV_Y_301	17%	20%	0.256	0.837	1.89	1.53	10	10	2	0	100%	0.7
5L5Q_6NV_Y_301	42%	20%	0.207	0.927	1.84	1.56	11	10	2	0	100%	1
5L5V_6NV_K_301	26%	18%	0.239	0.884	1.95	1.6	11	11	2	0	100%	0.9
5L55_6NV_K_301	53%	19%	0.172	0.935	1.84	1.63	10	12	0	0	100%	1
5L64_6NV_K_301	21%	16%	0.25	0.86	1.82	1.9	10	14	0	0	100%	0.8

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.